Naturhouse Health (XMAD:NTH) Beta: 0.3379 (As of Jun. 25, 2026)


XMAD:NTH Naturhouse Health SA XMAD:NTH
81 GF Score
Price €2.53
GF Value €1.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Naturhouse Health Beta?

Naturhouse Health XMAD:NTH -0.78% 81 Beta is 0.3379 as of Jun. 25, 2026. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Naturhouse Health's Beta is 0.3379.


Naturhouse Health  (XMAD:NTH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Naturhouse Health Beta Related Terms


Naturhouse Health Beta Historical Data

* Premium members only.

The historical data trend for Naturhouse Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturhouse Health Beta Chart

Naturhouse Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 0.97 0.32 0.44 0.60

Naturhouse Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.40 0.44 0.41 0.60

XMAD:NTH vs KHC, GIS, JBS: Beta Comparison

For the Packaged Foods subindustry, Naturhouse Health's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturhouse Health Beta vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Beta distribution charts can be found below:

* The bar in red indicates where Naturhouse Health's Beta falls into.


XMAD:NTH
81GF Score
Naturhouse Health SA XMAD:NTH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturhouse Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3379 mean?
Naturhouse Health (XMAD:NTH) has a Beta of 0.3379 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Naturhouse Health and its competitors.
Is Naturhouse Health's Beta too high?
Naturhouse Health's current Beta is 0.3379. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Beta compare to KHC and GIS?
Naturhouse Health's Beta of 0.3379 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Consumer Packaged Goods company?
A good Beta depends on the Consumer Packaged Goods industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Naturhouse Health and its competitors. Naturhouse Health's current Beta is 0.3379. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.53 — trading 56.2% above its estimated fair value. The current Beta is 0.3379. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Beta is 0.3379 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?

Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued. The current stock price of €2.53 is trading 56.2% above its estimated GF Value™ of €1.62. GuruFocus considers Naturhouse Health to be Significantly Overvalued.

Key valuation signals for XMAD:NTH:

  • Beta: 0.3379
  • GF Value™: €1.62 vs. price of €2.53 (56.2% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturhouse Health Business Description

Other Exchanges 0R9G:UK2NH:Germany
Address Calle Claudio Coello, 91, 4º Planta, Madrid, ESP, 28006
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score

Get the complete analysis for XMAD:NTH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.53
Price
€1.62
GF Value